Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by maurizio parodi
Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical Ophthalmology
Ophthalmology
Related publications
Cost-Effectiveness of Ranibizumab Versus Aflibercept in the Treatment of Visual Impairment Due to Diabetic Macular Edema: A UK Healthcare Perspective
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
The Macular Function and Structure in Patients With Diabetic Macular Edema Before and After Ranibizumab Treatment
Documenta Ophthalmologica
Ophthalmology
Sensory Systems
Physiology
Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Comparison Study of Efficacyinvolving Intravitreal Ranibizumab Versus Standard Laser Mono Therapy in Patients With Visual Impairment Due to Diabetic Macula Edema
IOSR Journal of Dental and Medical Sciences
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Sub-Macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
Case Medical Research
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
